Shares of Ultragenyx are sharply climbing this morning after the company announced positive results from its Phase III study of burosumab in adults with XLH. Source: BioSpace

Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales. Source: BioSpace

In an analysis of BMS' recent clinical history, Industry analysts at Trefis noted that two oncology drugs will be key revenue drivers for the company. Source: BioSpace

Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013. Source: BioSpace

There are some changes taking place in the C-suites at Shire. Source: BioSpace

HeartFlow makes software that builds a 3D model of your heart’s arteries, based on CT scans. Source: BioSpace

Foundation Medicine's sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday. Source: BioSpace

The spike began after the six-person company announced it had entered into a multi-year services agreement with Merck KGaA. Source: BioSpace

An IDMC told Bayer that it should unblind its Phase III clinical trial in prostate cancer in order to further analyze an increased number of fractures and deaths. Source: BioSpace

These great biotech stocks to buy for the holidays come in all sizes -- small-cap, mid-cap, and large-cap. Source: BioSpace